Latest Breaking News On - Coalition for hemophilia - Page 1 : comparemela.com

FDA Approves Fidanacogene Elaparvovec-dzkt as One-Time Gene Therapy for Adults With Hemophilia B

FDA Approves One-Time Gene Therapy Fidanacogene Elaparvovec for Hemophilia B

The FDA has approved fidanacogene elaparvovec-dzkt (Beqvez; Pfizer), a gene therapy administered in a one-time dose, for certain patients with moderate to severe hemophilia B.

FDA approves gene therapy for hemophilia B, now world's costliest medicine

The Food and Drug Administration has approved a gene therapy treatment for adults with hemophilia B that costs $3.5 million per dose, making it the world's most expensive medicine.

FDA approves gene therapy for hemophilia B, now world's costliest medicine

The Food and Drug Administration has approved a gene therapy treatment for adults with hemophilia B that costs $3.5 million per dose, making it the world's most expensive medicine.

FDA approves first gene therapy for Haemophilia B

Hemgenix, the first gene therapy for adults with Haemophilia B has been approved by the US Food and Drug Administration (FDA).